Literature DB >> 19297609

Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines.

Yongxiu Yao1, Yuguang Zhao1, Lorraine P Smith1, Charles H Lawrie2, Nigel J Saunders3, Michael Watson1, Venugopal Nair1.   

Abstract

MicroRNAs (miRNAs) are increasingly recognized to play crucial roles in regulation of gene expression in different biological events, including many sporadic forms of cancer. However, despite the involvement of several viruses in inducing cancer, only a limited number of studies have been carried out to examine the miRNA expression signatures in virus-induced neoplasia, particularly in herpesvirus-induced tumours where virus-encoded miRNAs also contribute significantly to the miRNome of the tumour cell. Marek's disease (MD) is a naturally occurring, rapid-onset CD4+ T-cell lymphoma of poultry, induced by the highly contagious Marek's disease virus (MDV). High levels of expression of virus-encoded miRNAs and altered expression of several host-encoded miRNAs were demonstrated in the MDV-transformed lymphoblastoid cell line MSB-1. In order to identify the miRNA expression signature specific to MDV-transformed cells, we examined the global miRNA expression profiles in seven distinct MDV-transformed cell lines by microarray analysis. This study revealed that, in addition to the high levels of MDV-encoded miRNAs, these MD tumour-derived lymphoblastoid cell lines showed altered expression of several host-encoded miRNAs. Comparison of the miRNA expression profiles of these cell lines with the MDV-negative, retrovirus-transformed AVOL-1 cell line showed that miR-150 and miR-223 are downregulated irrespective of the viral aetiology, whereas downregulation of miR-155 was specific for MDV-transformed tumour cells. Thus, increased expression of MDV-encoded miRNAs with specific downregulation of miR-155 can be considered as unique expression signatures for MD tumour cells. Analysis of the functional targets of these miRNAs would contribute to the understanding of the molecular pathways of MD oncogenicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297609     DOI: 10.1099/vir.0.009902-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  27 in total

1.  The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.

Authors:  Grégoire Stik; Ginette Dambrine; Sébastien Pfeffer; Denis Rasschaert
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

2.  A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.

Authors:  Ling Lian; Lujiang Qu; Yanmei Chen; Susan J Lamont; Ning Yang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

3.  MicroRNA-26a-mediated regulation of interleukin-2 expression in transformed avian lymphocyte lines.

Authors:  Hongtao Xu; Yongxiu Yao; Lorraine P Smith; Venugopal Nair
Journal:  Cancer Cell Int       Date:  2010-05-04       Impact factor: 5.722

4.  The chicken miR-150 targets the avian orthologue of the functional zebrafish MYB 3'UTR target site.

Authors:  Audrey Guillon-Munos; Ginette Dambrine; Nicolas Richerioux; Damien Coupeau; Benoît Muylkens; Denis Rasschaert
Journal:  BMC Mol Biol       Date:  2010-09-02       Impact factor: 2.946

5.  Genome-wide analysis of circular RNAs involved in Marek's disease tumourigenesis in chickens.

Authors:  Lulu Wang; Zhen You; Mingyue Wang; Yiming Yuan; Changjun Liu; Ning Yang; Hao Zhang; Ling Lian
Journal:  RNA Biol       Date:  2020-01-17       Impact factor: 4.652

6.  Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.

Authors:  Shyamesh Kumar; Dusan Kunec; Joram J Buza; Hsin-I Chiang; Huaijun Zhou; Sugalesini Subramaniam; Ken Pendarvis; Hans H Cheng; Shane C Burgess
Journal:  BMC Syst Biol       Date:  2012-09-14

7.  Clonal structure of rapid-onset MDV-driven CD4+ lymphomas and responding CD8+ T cells.

Authors:  William N Mwangi; Lorraine P Smith; Susan J Baigent; Richard K Beal; Venugopal Nair; Adrian L Smith
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

8.  Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas.

Authors:  Yuguang Zhao; Hongtao Xu; Yongxiu Yao; Lorraine P Smith; Lydia Kgosana; James Green; Lawrence Petherbridge; Susan J Baigent; Venugopal Nair
Journal:  PLoS Pathog       Date:  2011-02-24       Impact factor: 6.823

9.  Epigenetic Silencing of MicroRNA-126 Promotes Cell Growth in Marek's Disease.

Authors:  Isabelle Gennart; Astrid Petit; Laetitia Wiggers; Srđan Pejaković; Nicolas Dauchot; Sylvie Laurent; Damien Coupeau; Benoît Muylkens
Journal:  Microorganisms       Date:  2021-06-21

Review 10.  miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation.

Authors:  Peng Jiao; Xing-Ping Wang; Zhuo-Ma Luoreng; Jian Yang; Li Jia; Yun Ma; Da-Wei Wei
Journal:  Int J Biol Sci       Date:  2021-06-04       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.